Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bone Marrow Transplantation|March 14, 2003
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastimL B To, J Bashford, S Durrant, et al.Annals of Internal Medicine|August 1, 1993
Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 yearsD I Marks, J O Cullis, K N Ward, et al.Bone Marrow Transplantation|October 11, 2001
Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationP Ljungman, K N Ward, B N Crooks, et al.Leukemia|October 3, 2003
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phaseS Branford, Z Rudzki, A Harper, et al.British Journal of Haematology|March 1, 1997
Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological controlT P Hughes, A Grigg, J Szer, et al.Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaP Mollee, C Arthur, T Hughes, et al.Leukemia & Lymphoma|June 28, 2001
A prospective randomized study of Chop versus Chop plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: the International Oncology Study Group NHL1 StudyF J Giles, J Shan, S H Advani, et al.Pageof 5